Clinical Trial Update: Lorcaserin and Behavioral Modification for Overweight and Obesity Management in Chinese Obese Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update on lorcaserin with behavioral modification for overweight/obesity in Chinese patients; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Lorcaserin (lorcaserin)

Snippet

Sponsor: Kanion & Huawe Medicine Co.,Ltd | Conditions: Obesity | Phase 3 | Status: TERMINATED